Back to UBS Group AG UBS Group AG

DNADNA
8 quarters

Position history for UBS Group AGUBS Group AG's holdings in GINKGO BIOWORKS HOLDINGS INC

UBS Group AG holds 691,659 shares of DNA (GINKGO BIOWORKS HOLDINGS INC), worth $6.9M as of 2026-Q2. The position was increased (+18.7% shares). DNA represents 0.0% of UBS Group AG's portfolio.

Current Value

$6.9M

Current Shares

691,659

Total Value Change

+$6.7M

Total Shares Change

+674,919

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
691,659
+18.7%
$6.9M0.0%$9.91
32
2026-Q1
Increased
582,799
+19.1%
$3.6M0.0%$6.70
31
2025-Q4
Increased
489,418
+86.4%
$4.1M0.0%$8.15
42
2025-Q3
Decreased
262,557
-15.8%
$3.8M0.0%$13.23
0
2025-Q2
Increased
311,956
+10.4%
$3.5M0.0%$9.46
29
2025-Q1
Decreased
282,616
-26.9%
$1.6M0.0%$6.12
0
2024-Q4
Increased
386,347
+2207.9%
$3.8M0.0%$9.44
43
2024-Q3
New
16,740
-
$136,4320.0%$8.09
34

Other major holders of DNA: VIKING GLOBAL INVESTORS LP, BlackRock, Inc., BAILLIE GIFFORD & CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used